制药公司和谐生物科学公司(Harmony Biosciences Holdings, Inc.)股价今日盘中大涨16.14%,主要受公司刚公布的超预期第三季度财报数据所推动。
根据公司27日晚间发布的最新季报,第三季度和谐生物实现营收1.86亿美元,超过分析师平均预期的1.84亿美元。公司同期每股收益为79美分,较去年同期的63美分有所增长。
业绩向好令投资者对该公司前景看好,并借此机会加码布局。截至上一交易日,和谐生物股价已累积上涨10.7%。市场预期公司业绩表现良好进一步推升当日大涨。分析师认为,和谐生物科学的优异财报反映了公司产品竞争力及未来发展潜力,给予"买入"等积极评级,成为推动股价上涨的主因。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.